Literature DB >> 2536543

An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids.

G W Bazill1, T M Dexter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2536543     DOI： 10.1016/0006-2952(89)90053-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

Review 1.  Cell-signaling targets for antitumour drug development.

Authors:  V G Brunton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Autoradiographic localization of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period.

Authors:  G B Kudolo; M Kasamo; M J Harper
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

3.  Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.

Authors:  F E Bishop; C Dive; S Freeman; A Gescher
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives.

Authors:  H Naundorf; E C Rewasowa; I Fichtner; B Büttner; M Becker; M Görlich
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.624

5.  In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.

Authors:  V G Brunton; P Workman
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.